RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Hikma Ventures
H

Hikma Ventures portfolio

Hikma Ventures has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Biolinq's $100M Series B+ round in April 2025, alongside Taisho Pharmaceutical Holdings, RiverVest, M Ventures and 5 others. That company is in Health and bio. It has co-invested with M Ventures, LifeSci Venture Partners and Taisho Pharmaceutical Holdings, most often M Ventures (4 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $214.75M.
Latest deal: Biolinq · Apr 22, 2025.

What Hikma Ventures invests in

Hikma Ventures recent investments

CompanyRoundDateAlongside
BBiolinqSeries B+ · $100MTaisho Pharmaceutical Holdings, RiverVest, M Ventures +5
BBiolinqSeries B+ · $100MT&W Medical, The Broe Group, Taisho Pharmaceutical Holdings +6
BBiolinqSeries A · $4.75MM Ventures, LifeSci Venture Partners (lead), JDRF T1D Fund (lead) +1
BBiolinqSeries A · $10MThree Leaf Ventures, M Ventures (lead), LifeSci Venture Partners +1

How Hikma Ventures invests

StageDealsCapital in rounds
Series B+ 2 50%$200M
Series A 2 50%$14.75M
YearDealsCapital in rounds
2017 1 25%$10M
2019 1 25%$4.75M
2021 1 25%$100M
2025 1 25%$100M

Share is of the 4 rounds on Recent Funding that name Hikma Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Hikma Ventures portfolio companies

CompanyRound with Hikma VenturesTotal raisedLatest raise
BBiolinq
Health and bio
 Series B+ · $100M$214.75MApr 22, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Hikma Ventures, which is a subset of its real portfolio. API: /api/v1/investors/hikma-ventures (get a free API key). More: the most active VC firms and new venture capital funds.